@biggsy07
compared sgh WIP and Myx investment in brand r&d and product development is a ridiculous to say the least
SGH down fall cause by it count WIP as revenue even thought it has not received the cash, that close to cooking the book.
product development and research, myx don’t count that as revenue it is a cost to the balance sheet that it
may or may not pay off with new products.
amazon making no money for years all the money go back into developing their infrastructure and better
IT system, so to the outsider this guy is not making a cent but adding back all the money it spend on r&d and development it is very profitable, these days they just ripped the benefits of those early investment and the rest is history, bad luck for the guys that just looking at headlines.
- Forums
- ASX - By Stock
- CEO Scott Richards - has to go
MYX
mayne pharma group limited
Add to My Watchlist
0.20%
!
$5.08

@biggsy07 compared sgh WIP and Myx investment in brand r&d and...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.08 |
Change
0.010(0.20%) |
Mkt cap ! $412.7M |
Open | High | Low | Value | Volume |
$5.13 | $5.15 | $5.08 | $445.2K | 87.01K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 810 | $5.08 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.15 | 2033 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 810 | 5.080 |
2 | 3150 | 5.040 |
1 | 600 | 5.030 |
3 | 3000 | 5.000 |
1 | 10000 | 4.980 |
Price($) | Vol. | No. |
---|---|---|
5.150 | 2033 | 2 |
5.180 | 2396 | 2 |
5.190 | 5000 | 1 |
5.200 | 157 | 1 |
5.210 | 5000 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online